Kim Sablich

2018 - Myovant Sciences Ltd.

In 2018, Kim Sablich earned a total compensation of $2.4M as Chief Commercial Officer at Myovant Sciences Ltd..

Compensation breakdown

Bonus$105,000
Non-Equity Incentive Plan$47,000
Option Awards$1,474,406
Salary$133,333
Stock Awards$513,216
Other$87,958
Total$2,360,913

Sablich received $1.5M in option awards, accounting for 62% of the total pay in 2018.

Sablich also received $105K in bonus, $47K in non-equity incentive plan, $133.3K in salary, $513.2K in stock awards and $88K in other compensation.

Rankings

In 2018, Kim Sablich's compensation ranked 4,916th out of 14,244 executives tracked by ExecPay. In other words, Sablich earned more than 65.5% of executives.

ClassificationRankingPercentile
All
4,916
out of 14,244
66th
Division
Manufacturing
1,846
out of 5,765
68th
Major group
Chemicals And Allied Products
676
out of 2,128
68th
Industry group
Drugs
566
out of 1,817
69th
Industry
Pharmaceutical Preparations
435
out of 1,391
69th
Source: SEC filing on July 25, 2019.

Sablich's colleagues

We found four more compensation records of executives who worked with Kim Sablich at Myovant Sciences Ltd. in 2018.

2018

Lynn Seely

Myovant Sciences Ltd.

Principal Executive Officer

2018

Frank Karbe

Myovant Sciences Ltd.

Principal Financial and Accounting Officer

2018

Juan Ferreira

Myovant Sciences Ltd.

Chief Medical Officer

2018

Matthew Lang

Myovant Sciences Ltd.

General Counsel

News

In-depth

You may also like